By aligning internal operations with outsourced processes and offering hands-on QA management support, we ensured a smooth, compliant, and practical implementation
About this Case Study
This case study highlights how Rephine supported a fast-growing biotech company specialising in novel cancer biotherapeutics as it prepared to enter non-clinical and clinical trial phases. The company, recently spun out from two institutions, needed to establish a fully GMP-compliant Quality Management System (QMS) to support its Investigational Medicinal Product (IMP) operations.
Facing challenges such as a lack of internal GMP knowledge and key roles being managed by external consultants, the company required a flexible yet robust QMS tailored to its structure and regulatory needs. Rephine delivered a scalable system, embedded QA oversight, and ensured alignment across internal teams and outsourced partners—achieving full GxP readiness and preparing the client for regulatory inspections.
Download the full case study now and discover how Rephine helped a biotech company achieve GMP compliance for their IMP operations.
Download the Case Study
View other our other resources and company news
CSV Practical Guide to the EMA’s Draft EU GMP Revisions
Guide Practical Guide to Post-Market Surveillance (PMS) under EU MDR/IVDR
Blog AI for Pharmaceutical SOPs: Transforming Quality Management and Compliance
CAPA Strengthening CAPA & Exceptions Management
Blog EU GMP Annex 1 vs FDA Aseptic Guide: Bridging Compliance
Blog GMP & GDP: Ensuring Quality in Drug Storage and Transport
Blog Blockchain for GMP Documentation: Hype or Future Reality?
Guide Is Your Insurance Policy Ready for the New EU Product Liability Directive?
Article 